The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

NanoViricides Inc. (NYSE American: NNVC)

Investment Considerations NanoViricides is pioneering a novel class of nanomedicine-based antiviral therapies, offering a unique and potentially disruptive approach to treating a broad range of viral infections. The company’s lead candidate, NV-387, has shown promising preclinical results against major respiratory viruses like Influenza, COVID-19, and RSV, positioning it as a strong contender in the multi-billion-dollar … Continue reading “NanoViricides Inc. (NYSE American: NNVC)”

View Profile